Search Results - K. A. Yatsenko

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    REGULATORY STRATEGY OF CLINICAL DEVELOPMENT FOR FIXED COMBINATION MEDICINAL PRODUCTS

    REGULATORY STRATEGY OF CLINICAL DEVELOPMENT FOR FIXED COMBINATION MEDICINAL PRODUCTS by K. A. Yatsenko, V. S. Berezina

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    CLINICAL DEVELOPMENT STRATEGY FOR COPIES OF PREVIOUSLY REGISTERED DRUGS. PART 3. PROTOCOL OF CLINICAL TRIAL OF BIOEQUIVALENCE

    CLINICAL DEVELOPMENT STRATEGY FOR COPIES OF PREVIOUSLY REGISTERED DRUGS. PART 3. PROTOCOL OF CLINICAL TRIAL OF BIOEQUIVALENCE by K. A. Yatsenko, E. A. Kuznetsov, A. V. Arkadjeva, V. S. Berezina

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials

    Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials by V. S. Kosorukov, G. R. Abuzarova, E. R. Zakharochkina, O. Yu. Gamzeleva, K. A. Yatsenko

    Published 2022-08-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: